Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00064246
Status:
COMPLETED
Last Update Posted:
2013-01-25
First Post:
2003-07-08
Brief Title:
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Post-transplant Lymphoproliferative Disorder |
| Recurrent Adult Burkitt Lymphoma |
| Recurrent Adult Diffuse Large Cell Lymphoma |
| Stage III Adult Burkitt Lymphoma |
| Stage III Adult Diffuse Large Cell Lymphoma |
| Stage IV Adult Burkitt Lymphoma |
| Stage IV Adult Diffuse Large Cell Lymphoma |
| Waldenström Macroglobulinemia |
Keywords: